IBRUTINIB FOLLOWED BY OFATUMUMAB CONSOLIDATION IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): GELLC‐7 TRIAL FROM THE SPANISH GROUP OF CLL (GELLC) | Publicación